Skip to content

Comparison of the effects of Hyoscine and Acupressure on Hugo point on length of delivery

Comparison of the effects of Hyoscine and Acupressure on Hugo point (LI 4) on Length of delivery stages in nuliparous women: A randomized controlled clinical trial.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201709293027N39
Enrollment
162
Registered
2017-11-10
Start date
2017-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery. Spontaneous vertex delivery

Interventions

Intervention 1: Acupuncture Hugo Point: At 5 cm dilatation, the Hugo point will be pressed gently for 30 seconds, and gradually the pressure will be added to become quite severe so that the patient fe
Prevention
Acupuncture Hugo Point: At 5 cm dilatation, the Hugo point will be pressed gently for 30 seconds, and gradually the pressure will be added to become quite severe so that the patient feels numbed and h
Injection of Hyoscine: At the onset of the delivery phase (dilation of 5 cm), 20 milligrams of Hyoscine will be injected muscularly and every 2 to 3 hours vaginal examination will be done. Primery ou
Control group: The researcher will attend the maternity clinic and all routine lab measures that will be performed in the two intervention groups will be performed except acupressure and hyosteine inj

Sponsors

Research Deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 18 to 35 years old, gestational age of 37 to 42 weeks (according to LMP or ultrasound in less than 12 weeks),nulliparous, singleton pregnancy, cephalic presentation, intact amniotic sac at examination, or passing Maximum 6 hours of rupture of the amniotic sac, spontaneous onset of uterine contraction, having low risk pregnancy (such as the absence of chronic disease like heart disease, hypertension, lung disease, diabetes, anemia, urinary tract infection, thyroid disease, and epilepsy; not having abortion, dead fetus, bleeding or any abnormality when referring to the hospital); absence of cephalopelvic disproportion (CPD) during vaginal examination; height over 145 cm; no lesion in hugo points; not presence of any disabilities that lead to communication problems for the mother (deafness, blindness, etc.).Exclusion Criteria: meconium-rich amniotic fluid; Any need for emergent intervention in mothers and fetuses such as bleeding, Burst contractions, Labor accelerated, Fetal distress,Placenta Decolman.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lenght of active phase of labor. Timepoint: Every 2-3 hours, from the onset of the active phase of labor to its completion and the onset of the second stage of labor. Method of measurement: With vaginal exame and registration in the form of a partographer.;The length of the second stage of labor. Timepoint: Every 30 minutes once, from the onset of the second stage of childbirth to its completion. Method of measurement: Via vaginal examination and recording in the form of a partogragh.

Secondary

MeasureTime frame
Length of the third stage of labor. Timepoint: After completing the third stage of labor. Method of measurement: Observe and determine the time using the clock and record in the partograph.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Sehhatie Shafaie

Tabriz University of Medical Sciences

sehhatief@tbzmed.ac.ir+98 41134796770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026